Skip to main content
European Thyroid Journal logoLink to European Thyroid Journal
. 2017 Aug 12;6(Suppl 1):1–22. doi: 10.1159/000477985

Scientific Programme

PMCID: PMC5611889  PMID: 29082209

Pre-Conference Events

Saturday, 9th September 2017

Room Pacific

08.00–13.00

ETA Clinical Educational Course

Primary Hypothyroidism

Room Morava

08.00–13.00

ETA Basic Educational Course

Room Atlantic 1

08.30–13.00

ETA-CRN Symposium

Management of High-Risk Differentiated Thyroid Cancer

Room Atlantic 3

08.00–13.00

IGN – EUthyroid Satellite Meeting

Iodine – The European Landscape

Room Aegean

08.00–13.00

ETA Ultrasound Course

Advanced Thyroid, Neck Ultrasonography and Ultrasound-Assisted Procedures

13.00–13.45

Lunch

ETA Clinical Educational Course

Primary Hypothyroidism

Room Pacific

08.00–13.00

Chair: Tomasz Bednarczuk, Poland and Thomas Brix, Denmark
08.00–08.30 Epidemiology and cause of hypothyroidism Allan Carlé, Denmark
08.30–09.00 Hypothyroidism – diagnosis and clinical picture Stefano Mariotti, Italy
09.00–09.30 Congenital hypothyroidism, cause and long-term neurocognitive consequences Paul van Trotsenburg, The Netherlands
09.30–10.00 Coffee break
10.00–10.30 Treatment of hypothyroidism and how to monitor/evaluate the effect of treatment Colin Dayan, UK
10.30–11.00 Pharmacogenetics in hypothyroidism, present evidence and future perspective Robin Peeters, The Netherlands
11.00–11.30 Burden of co-morbidity and mortality risk in hypothyroidism – fact or artefact? Thomas Brix, Denmark
11.30–12.00 Coffee break
12.00–12.30 Hypothyroidism and hypothyroxinemia in pregnancy Bijay Vaidya, UK
12.30–13.00 Subclinical hypothyroidism – who should be treated Simon Pearce, UK

ETA Basic Educational Course

Room Morava

08.00–13.00

Chairs: Anita Boelen, The Netherlands and Theo Visser, The Netherlands
Introduction
08.00–08.30 Overview of thyroid hormone action Duncan Bassett, UK
Molecular Biology
08.30–09.00 Classical actions of thyroid hormone receptors Karine Gauthier-Vanacker, France
09.00–09.30 Thyroid hormone receptors and chromatin Ana Aranda, Spain
09.30–10.00 Non-classical actions of thyroid hormone receptors Lars Möller, Germany
10.00–10.30 Coffee break
Physiology
10.30–11.00 Amphibian metamorphosis Laurent Sachs, France
11.00–11.30 Thyroid hormone and development Douglas Forrest, USA
11.30–12.00 Thyroid hormone action – central and peripheral metabolic effects Eric Fliers, The Netherlands
Pathology
12.00–12.30 Resistance to thyroid hormone – human Krishna Chatterjee, UK
12.30–13.00 Resistance to thyroid hormone – mice Graham Williams, UK

ETA-CRN Symposium

Management of High-Risk Differentiated Thyroid Cancer

Room Atlantic 1

08.30–13.00

08.30 Welcome address
Session I: Chairs: Kate Newbold, UK and Dagmar Führer, Germany
08.40–09.10 Surgical approach to the patient Peter Goretzki, Germany
09.10–09.50 Histological and molecular features of high-risk thyroid cancer
• Histology aspects Paula Soares, Portugal
• Genetic aspects Rossella Elisei, Italy
09.50–10.20 Risk stratification and follow-up Mike Tuttle, USA
10.20–10.50 Discussion
10.50–11.20 Coffee break
Session II: Chairs: Laura Fugazzola, Italy and Markus Luster, Germany
11.20–11.50 Strategies for radioiodine and external radiation Daria Handkiewicz-Junak, Poland
11.50–12.10 Side effects of radioiodine Esther N. Klein Hesselink, The Netherlands
12.10–12.30 Quality of life Olga Husson, The Netherlands
12.30–13.00 Roundtable discussion
13.00 Closing remarks and lunch

graphic file with name etj-0006-0001-gu01.jpg

Iodine Global Network – EUthyroid Satellite Meeting

Room Atlantic 3

08.00–13.00

graphic file with name etj-0006-0001-gu02.jpg

08.00–08.25 Registration and coffee
08.25–08.30 Introduction John Lazarus (IGN Regional Coordinator)
Iodine – The European Landscape
Chairs: Robin Peeters, The Netherlands and Lisbeth Dahl, Norway
08.30–08.50 EUthyroid – update 2017 Henry Völzke, Germany
08.50–09.10 Progress and sustainability of salt iodisation in CEE/CIS countries – review of Sarajevo meeting Ludmila Ivanova, Bulgaria
09.10–09.30 What do we need to evaluate IDD prevention? Monika Buchberger, Austria
09.30–09.50 Country profile – Turkey Murat Faik Erdoğan, Turkey
09.50–10.30 Coffee/tea and posters
Chairs: John Lazarus, UK, and Aron Troen, Israel
10.30–10.50 Has the UK really become iodine sufficient? Sarah Bath, UK
10.50–11.10 Improving the iodine intake of the population – the Finnish experience Iris Erlund, Finland
11.10–11.30 Iodine deficiency in Europe: the utopia of having a European health policy Wouter Lox, Belgium
11.30–11.50 Development of the World Iodine Association Katja Hora, Belgium
11.50–12.30 Universal salt iodisation in CEE and Central Asia: the role of UNICEF, the challenges and the way forward Amirhossein Yarparvar, Kazakhstan
12.30–13.00 Lunch and close

graphic file with name etj-0006-0001-gu03.jpg

This project has received funding from the European Union's Horizon 2020 Research and Innovation Programme under Grant Agreement No. 634453

Iodine Global Network

Regional Coordinator West and Central Europe: John Lazarus

Deputy Regional Coordinator: Paulo Vitti

Secretariat IGN West Central Europe E-Mail j.l.hickey@btf-thyroid.org

ETA Ultrasound Course

Advanced Thyroid, Neck Ultrasonography and

Ultrasound-Assisted Procedures

Room Aegean

08.00–13.00

08.00–08.10 Welcome Miloš Žarković, Serbia
Session 1: Thyroid Nodule and Cancer
08.10–08.30 Risk factors for thyroid nodules and cancer Paolo Vitti, Italy
Teaching aim: To identify patients who are suitable candidates for US exam and FNA
08.30–08.55 Risk stratification of thyroid nodules with the EU-TIRADS and indications for FNA Gilles Russ, France
Teaching aim: To learn how to stratify thyroid nodules with US
08.55–09.15 FNA of thyroid nodules: how I do it Teresa Rago, Italy
Teaching aim: Introduction to thyroid FNAB, pitfalls and limits
09.15–09.55 Recurrences of thyroid cancer
Ultrasound in thyroid cancer patients Laurence Leenhardt, France
Teaching aim: Follow-up of thyroid cancer patients
Cervical lymph nodes mapping: where to search and criteria for recurrence Cosimo Durante, Italy
Teaching aim: Criteria for malignancy, neck classification and landmarks
09.55–10.15 Quiz 1, 2, 3, 4 Rose N'gu, UK
10.15–10.30 Coffee break
Session 2: Auto-Immune Diseases, Parathyroid and Interventional Imaging
10.30–10.50 Ultrasound features of auto-immune diseases and estimation of thyroid volume Steen Bonnema, Denmark
Teaching aim: US criteria for AI diseases, US evaluation of thyroid gland for RAI therapy
10.50–11.10 US of parathyroid adenomas: typical aspects and pitfalls Murat Erdogan, Turkey
Teaching aim: Where to search parathyroid glands
11.10–11.30 Laser or percutaneous ethanol injection of thyroid nodules and lymph nodes Enrico Papini, Italy
Teaching aim: Indications, technique and results
Session 3: Hands-On Ultrasound
11.30–13.00 An ultrasound experience with instructors on thyroid patients and phantoms

Sunday, 10th September 2017

graphic file with name etj-0006-0001-gu04.jpg

50th Anniversary Historical Symposium

Room Pacific Chairs:

15.10–16.00 Pilar Santisteban, ETA President, Spain

Peter Smyth, Chair ETA Archives Board, Ireland

Welcome, ETA President

Pilar Santisteban, Spain

Advances in Thyroidology 1967–2017

Jacques Orgiazzi, France

Evolution of the ETA Annual Meeting (Meeting Statistics)

Wilmar Wiersinga, The Netherlands

History of Annual Meetings

Peter Smyth, Ireland

Development of the ETA – An Outsider's View

Annemarie van Eekelen, The Netherlands

Presentation of the ETA 50th Anniversary Book to the ETA President

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):9.

Scientific Programme


⁕

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):9.

Saturday, 9th September 2017


⁕

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):9.

13.45–14.00 Opening Ceremony


Chairs: Pilar Santisteban, ETA President, Spain

Miloš Žarković, Chair of the Local Organizing Committee, Serbia

Words of Welcome

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):9.

14.00–16.00 Oral Session 1: Topic Highlights


Chairs: Pilar Santisteban, Spain

Miloš; Žarković, Serbia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):9.

14.00–14.15 OP–01–01 A NOVEL MOUSE MODEL DEMONSTRATES THE PATHOGENIC ROLE OF ACTIVATING ALK MUTATIONS IN POORLY DIFFERENTIATED THYROID CARCINOMA


Presenting Author: Lars Christian Möller, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):9.

14.20–14.35 OP–01–02 IDENTIFICATION OF A DNA METHYLATION SIGNATURE THAT CAN PREDICT DISTANT METASTASES IN THYROID CANCER


Presenting Author: Mireia Jorda, Spain

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):9.

14.40–14.55 OP–01–03 LOW-NORMAL THYROID FUNCTION ASSOCIATED WITH INCREASED LIFE EXPECTANCY: THE ROTTERDAM STUDY


Presenting Author: Arjola Bano, The Netherlands

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):9.

15.00–15.15 OP–01–04 BMP/FGF-DEPENDENT DIFFERENTIATION OF THYROID CELLS FROM A NOVEL THYROID PROGENITOR CELL POPULATION IN ZEBRAFISH FOREGUT ENDODERM


Presenting Author: Robert Opitz, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):9.

15.20–15.35 OP–01–05 PROSTAGLANDIN F2-ALPHA EYE DROPS (BIMATOPROST) IN THYROID EYE DISEASE: A RANDOMISED CONTROLLED DOUBLE BLIND CROSSOVER TRIAL (BIMA STUDY)


Presenting Author: Mohd Shazli Draman, UK

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):9.

15.40–15.55 OP–01–06 DIVERSE FUNCTIONAL IMPAIRMENT OF THYROID HORMONE RECEPTOR ALPHA MUTATIONS


Presenting Author: Karn Wejaphikul, The Netherlands

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):9.

16.00–17.00 Poster Session 1


P1-01-01 – P1-06-54 (for corresponding Abstracts, see pp. 60–77)

P1 – 01 Autoimmunity 1 (Room Aegean)

Chair: Tomasz Bednarczuk, Poland

P1 – 02 Cancer Diagnosis (Room Mediterranean)

Chair: Furio Pacini, Italy

P1 – 03 Cancer Prognostic Factors (Room Tisa)

Chair: Efisio Puxeddu, Italy

P1 – 04 Goitre and Nodules 1 (Room Adriatic)

Chair: Leonidas Duntas, Greece

P1 – 05 Hyper- and Hypothyroidism (Room Baltic)

Chair: Thomas Brix, Denmark

P1 – 06 Molecular Mechanisms of Thyroid Hormone Action (Room Danube)

Chair: Lars Möller, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):10.

17.00–18.00 ETA Industry-Sponsored Satellite Symposium 1


(see p. 121 for details)

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):10.

18.15–19.00 ETJ Lecture


Chair: Wilmar Wiersinga, The Netherlands

The colorful diversity of thyroid hormone metabolites – autonomy for target cells of thyroid hormone action? Josef Köhrle, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):10.

19.30–22.00 Welcome Reception


(see p. 134 for details)

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):11.

Sunday, 10th September 2017


⁕

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):11.

07.00–08.00 ETA Industry-Sponsored Satellite Symposium 2


(see p. 122 for details)

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):11.

08.00–09.30 Symposium 1 (Translational): Targeting Tissue-Specific Thyroid Hormone Action


Chairs: Monica Dentice, Italy

Theo Visser, The Netherlands

08.00–08.30 Physiological consequences of human type 2 deiodinase polymorphism Antonio Bianco, USA
08.30–09.00 Muscle-specific action of thyroid hormone Domenico Salvatore, Italy
09.00–09.30 Tissue-specific targeting of thyroid hormone agonists Timo Müller, Germany
Eur Thyroid J. 2017 Aug 12;6(Suppl 1):11.

08.00–09.30 Symposium 2 (Basic): Redifferentiation in Thyroid Cancer


Chairs: Rossella Elisei, Italy

Cristina Romei, Italy

08.00–08.30 PBF oncogene and NIS repression Christopher McCabe, UK
08.30–09.00 Oxidative stress silences the transcription of genes involved in Iodide metabolism Corinne Dupuy, France
09.00–09.30 Reinduction of iodine uptake in BRAf-induced thyroid cancer James Fagin, USA
09.30–10.00 Coffee break
Eur Thyroid J. 2017 Aug 12;6(Suppl 1):11.

10.00–12.00 Oral Session 2 (Clinical): Clinical Aspects of Autoimmunity


Chairs: Mario Salvi, Italy

Mirjana Sumarac-Dumanovic, Serbia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):11.

10.00–10.10 OP–02–07 GENOTYPE-PHENOTYPE CORRELATIONS IN GRAVES' DISEASE


Presenting Author: Aleksander Kuś, Poland

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):11.

10.15–10.25 OP-02–08 DOES GRAVES' ORBITOPATHY (GO) EVER DISAPPEAR? ANSWERS TO AN OLD QUESTION


Presenting Author: Elena Sabini, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):11.

10.30–10.40 OP-02–09 MONTH OF BIRTH MAY AFFECT THE SUBSEQUENT RISK OF BEING DIAGNOSED WITH AUTOIMMUNE HYPOTHYROIDISM: A NATIONWIDE DANISH REGISTER-BASED STUDY


Presenting Author: Marianne Thvilum, Denmark

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):11.

10.45–10.55 OP-02–10 ASSOCIATION BETWEEN THE TIMESPAN UNTIL RADIOIODINE THERAPY AND THE DURATION OF GRAVES' ORBITOPATHY ACTIVITY


Presenting Author: Simona Gaberscek, Slovenia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):11.

11.00–11.10 OP-02–11 AUTOIMMUNE THYROID DISEASE AND FRACTURE RISK


Presenting Author: Snezana Polovina, Serbia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):11.

11.15–11.25 OP-02–12 DISEASE PRESENTATION AND REMISSION RATE IN GRAVES' DISEASE TREATED WITH ANTI-THYROID DRUGS: IS GENDER REALLY A FACTOR?


Presenting Author: Talia Diker-Cohen, Israel

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):11.

11.30–11.40 OP-02–13 GRAVES' ORBITOPATHY IS ASSOCIATED WITH AN INCREASED RISK OF UNNATURAL DEATH


Presenting Author: Thomas Brix, Denmark

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):12.

11.45–11.55 OP-02–14 ALEMTUZUMAB-INDUCED THYROID AUTOIMMUNITY: BIOLOGICAL CHARACTERISATION OF AUTOANTIBODIES TO THE THYROTROPIN RECEPTOR, AND POSSIBLE ROLE AS PREDICTIVE MARKER OF DISEASE


Presenting Author: Ilaria Muller, UK

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):12.

10.00–12.00 Oral Session 3 (Basic): Cancer – Scientific Aspects


Chairs: Clara Alvarez, Spain

Dubravka Cvejic, Serbia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):12.

10.00–10.10 OP-03–15 ANALYSIS OF THE BIOLOGICAL MECHANISMS DE-REGULATED AFTER PHARMACOLOGICAL BET INHIBITION IN ANAPLASTIC THYROID CANCER CELLS


Presenting Author: Catia Mio, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):12.

10.15–10.25 OP-03–16 INVESTIGATION OF THE ROLE OF OSTEOPONTIN IN CALCIFICATION AND MATRIX DEPOSITION IN THYROID CANCER


Presenting Author: Luciana Ferreira, Brazil

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):12.

10.30–10.40 OP-03–17 EGFR-TARGETED NONVIRAL NIS GENE TRANSFER FOR BIOIMAGING AND THERAPY OF DISSEMINATED COLON CANCER METASTASES


Presenting Author: Sarah Urnauer, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):12.

10.45–10.55 OP-03–18 MASSARRAY TECHNOLOGY FOR THE MUTATIONAL PROFILING OF PAPILLARY THYROID CANCER


Presenting Author: Marina Muzza, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):12.

11.00–11.10 OP-03–19 UNREVEALING METASTATIC DORMANCY IN THYROID CANCER: DIFFERENCES IN THE GENOTYPE BETWEEN SYNCHRONOUS AND METACHRONOUS METASTASES


Presenting Author: Miguel Melo, Portugal

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):12.

11.15–11.25 OP-03–20 AN INVESTIGATION INTO SODIUM-IODIDE SYMPORTER (NIS) DIMERISATION AND ITS IMPACT ON RADIOIODIDE UPTAKE IN THYROID CANCER


Presenting Author: Rebecca Thompson, UK

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):12.

11.30–11.40 OP-03–21 PD-L1 AND PD-L2 EXPRESSION IS INCREASED IN THYROID CARCINOMAS


Presenting Author: Efisio Puxeddu, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):12.

11.45–11.55 OP-03–98 REGIONAL HYPERTHERMIA FOR OPTIMIZATION OF EFFICACY AND TUMOR SELECTIVITY OF MESENCHYMAL STEM CELL (MSC)-MEDIATED SODIUM IODIDE SYMPORTER (NIS) GENE THERAPY


Presenting Author: Mariella Tutter, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):12.

12.00–13.00 Poster Session 2


P2-01-55 – P2-06-113 (for corresponding Abstracts, see pp. 77–96)

P2 – 01 Autoimmunity 2 (Room Tisa)

Chair: Stefano Mariotti, Italy

P2 – 02 Cancer Basic (Room Danube)

Chair: Romana T. Netea-Meier, The Netherlands

P2 – 03 Cancer Miscellaneous (Room Baltic)

Chair: Laurence Leenhardt, France

P2 – 04 Case Reports (Room Mediterranean)

Chair: Mirjana Stojkovic, Serbia

P2 – 05 Goitre and Nodules 2 (Room Adriatic)

Chair: Endre Nagy, Hungary

P2 – 06 Hypothyroidism (Room Aegean)

Chair: Valentin Fadeyev, Russian Federation

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):12.

13.00–14.00 ETA Industry-Sponsored Satellite Symposium 3


(see p. 123 for details)

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):13.

Meet the Expert 1–4


Room Pacific
14.00–14.45 MTE 1
Controversy in radioiodine treatment for thyroid cancer in the era of ATA guidelines Maria Grazia Castagna, Italy Markus Luster, Germany
Room Morava
14.00–14.45 MTE 2
Managememt of thyroid hormones resistance Paolo Beck-Peccoz, Italy
Room Atlantic 1
14.00–14.45 MTE 3
Measuring deiodinase activity and tissue thyroid hormone levels Anita Boelen, The Netherlands
Room Atlantic 3
14.00–14.45 MTE 4
Genome-wide mapping of thyroid hormone receptor transcriptional regulation Laurent Sachs, France
Eur Thyroid J. 2017 Aug 12;6(Suppl 1):13.

14.45–15.00 Coffee break


⁕

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):13.

15.00–15.10 Lissitzky Prize Award


Chair: Pilar Santisteban, Spain

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):13.

15.10–16.00 50th Anniversary Historical Symposium


Chairs: Pilar Santisteban, ETA President, Spain

Peter Smyth, Chair ETA Archives Board, Ireland

(see p. 8 for details)

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):13.

16.00–18.00 Oral Session 4 (Clinical): Cancer – Clinical and Diagnostic Aspects


Chairs: Laura Fugazzola, Italy

Milan Petakov, Serbia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):13.

16.00–16.10 OP-04–22 18F-DOPA PET/CT ASSESSMENT OF CERVICAL LYMPH NODE EXTENSION IN PATIENTS WITH MEDULLARY THYROID CARCINOMA


Presenting Author: Lavinia Vija Racaru, France

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):13.

16.15–16.25 OP-04–23 INCREASED INCIDENCE OF SECOND PRIMARY MALIGNANCY IN DIFFERENTIATED THYROID CANCER


Presenting Author: Noemi Fralassi, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):13.

16.30–16.40 OP-04–24 LONGITUDINAL ANALYSIS OF QUALITY OF LIFE IN PATIENTS TREATED FOR DIFFERENTIATED THYROID CANCER


Presenting Author: Evert van Velsen, The Netherlands

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):13.

16.45–16.55 OP-04–25 CHANGE IN CLINICAL PRESENTATION OF PAEDIATRIC DIFFERENTIATED THYROID CANCER – SINGLE-CENTRE EXPERIENCE OVER 40 YEARS


Presenting Author: Daria Handkiewicz-Junak, Poland

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):13.

17.00–17.10 OP-04–26 A RETROSPECTIVE ANALYSIS OF A COHORT OF 240 PATIENTS TREATED FOR MEDULLARY THYROID CANCER AT A SINGLE TERTIARY CARE CENTER SINCE 1960: FOCUS ON PROGNOSTIC FACTORS FOR SURVIVAL IN 41 PATIENTS WITH METASTATIC DISEASE


Presenting Author: Laurence Barde, France

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

17.15–17.25 OP-04–27 USE OF RECOMBINANT THYROID-STIMULATING HORMONE PRIOR TO RADIOACTIVE IODINE ADMINISTRATION AND THYROGLOBULIN TESTING – RESULTS OF A UK SURVEY


Presenting Author: Simon Duke, UK

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

17.30–17.40 OP-04–28 DOES THE 2015 ATA RISK STRATIFICATION SYSTEM PREDICT THE RISK OF PERSISTENT DISEASE? A PROSPECTIVE STUDY


Presenting Author: Livia Lamartina, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

17.45–17.55 OP-04–29 NEW POSSIBILITIES FOR IMAGING OF ADVANCED MEDULLARY THYROID CANCER – A CHALLENGE FOR TARGETED THERAPY


Presenting Author: Katja Zaletel, Slovenia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

16.00–18.00 Oral Session 5 (Basic): Intracellular Metabolism of Thyroid Hormone


Chairs: Veerle Darras, Belgium

Branka Sosic-Jurjevic, Serbia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

16.00–16.10 OP-05–30 PROTEOMIC ANALYSIS REVEALS METABOLIC PATHWAYS AFFECTED BY DECREASED EXPRESSION OF TYPE 1 IODOTHYRONINE DEIODINASE IN RENAL CANCER


Presenting Author: Agnieszka Piekielko-Witkowska, Poland

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

16.15–16.25 OP-05–31 OXIDATIVE STRESS INDUCES TYPE 3 DEIODINASE IN MULTIPLE TISSUE AFTER MYOCARDIAL INFARCTION: IMPLICATIONS TO NONTHYROIDAL ILLNESS SYNDROME PATHOPHYSIOLOGY


Presenting Author: Simone Wajner, Brazil

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

16.30–16.40 OP-05–32 INVOLVEMENT OF LAT3 IN THE UNIDIRECTIONAL TRANSPORT OF 3,3′-T2 ACROSS THE CELL MEMBRANE AND FIRST STRUCTURAL INSIGHTS BY HOMOLOGY MODEL GENERATION


Presenting Author: Katrin Manuela Hinz, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

16.45–16.55 OP-05–33 THYROID HORMONE AND SKIN CANCER: DYNAMIC CONTROL OF TUMOR FORMATION AND PROGRESSION BY DEIODINASES


Presenting Author: Monica Dentice, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

17.00–17.10 OP-05–34 SELECTIVE ACTIVATION/INACTIVATION OF THE THYROID HORMONE SIGNALING PATHWAY: THE METABOLIC CONSEQUENCES


Presenting Author: Karine Gauthier-Vanacker, France

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

17.15–17.25 OP-05–35 NON-GENOMIC EFFECTS OF THYROID HORMONES ON MESENCHYMAL STEM CELLS AND ANGIOGENESIS


Presenting Author: Kathrin Schmohl, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

17.30–17.40 OP-05–36 T3-RECEPTOR ALPHA 1 INTERACTOMES IN HUMAN LIVER AND NEURONAL CELLS


Presenting Author: Marcel Meima, The Netherlands

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

17.45–17.55 OP-05–37 Mct8 DEFICIENCY ALTERS NEURONAL GLUCOSE AND ENERGY METABOLISM


Presenting Author: Eva Katrin Wirth, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):14.

18.15–19.45 ETA Industry-Sponsored Satellite Symposium 4


(see p. 124 for details)

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15.

Monday, 11th September 2017


⁕

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15.

08.00–09.30 Symposium 3 (Clinical): Central Hypothyroidism


Chairs: Paolo Beck-Peccoz, Italy

Eric Fliers, The Netherlands

08.00–08.30 Novel genetic causes of isolated central hypothyroidism Paul van Trotsenburg, The Netherlands
08.30–09.00 The diagnosis of neonatal and acquired central hypothyroidism Nadia Schoenmakers, UK
09.00–09.30 The managment of central hypothyroidism Luca Persani, Italy
Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15.

08.00–09.30 Symposium 4 (Basic): Thyroid Hormone-Dependent Developmental Switches


Chairs: Ana Aranda, Spain

Barbara Demeneix, France

08.00–08.30 Amphibian and mouse development Valerie Galton, USA
08.30–09.00 Thyroid hormone receptor alpha isoforms in mammalian development Graham Richard Williams, UK
09.00–09.30 Thyroid hormone action in sensory organ development Douglas Forrest, USA
Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15.

09.30–10.00 Coffee break


⁕

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15.

10.00–12.00 Oral Session 6 (Clinical): Cancer – A Focus on Treatment


Chairs: Djuro Macut, Serbia

Malgorzata Oczko-Wojciechowska, Poland

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15.

10.00–10.10 OP-06–38 IMPACT OF MINIMAL EXTRA-THYROIDAL EXTENSION ON OUTCOME IN DIFFERENTIATED THYROID CANCER: SYSTEMATIC REVIEW AND META-ANALYSIS


Presenting Author: Eyal Robenshtok, Israel

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15.

10.15–10.25 OP-06–39 NEOADJUVANT VEMURAFENIB IN PATIENTS WITH LOCALLY ADVANCED PAPILLARY THYROID CANCER (PTC)


Presenting Author: Maria E. Cabanillas, USA

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15.

10.30–10.40 OP-06–40 ROLE OF RADIOACTIVE IODINE IN PATIENTS WITH T1b DIFFERENTIATED THYROID CARCINOMA


Presenting Author: Simone de Leo, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15.

10.45–10.55 OP-06–41 METASTATIC MEDULLARY THYROID CARCINOMA (MTC): DISEASE COURSE AND TREATMENT MODALITIES


Presenting Author: Katerina Saltiki, Greece

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15.

11.00–11.10 OP-06–42 FDG+/RAI+ PATIENTS WITH DISTANT METASTASES FROM DIFFERENTIATED THYROID CANCER CAN BENEFIT FROM RADIOACTIVE IODINE TREATMENT


Presenting Author: Sophie Leboulleux, France

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15.

11.15–11.25 OP-06–43 V804M RET MUTATION AND VANDETANIB RESPONSE IN METASTATIC MEDULLARY THYROID CANCER


Presenting Author: Laura Valerio, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15.

11.30–11.40 OP-06–44 OUTCOME AFTER LOBECTOMY FOR DIFFERENTIATED THYROID CANCER IN A SERIES OF 291 CONSECUTIVE CASES


Presenting Author: Francoise Borson-Chazot, France

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):15–16.

11.45–11.55 OP-06–45 ACTIVE SURVEILLANCE IN PAPILLARY THYROID MICROCARCINOMAS (PMCS): A 2-YEAR FOLLOW-UP (FU) AT A SINGLE CENTER


Presenting Author: Letizia Pieruzzi, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):16.

10.00–12.00 Oral Session 7 (Basic): Mechanisms of Thyroid Hormone Action in Brain and Thyroid


Chairs: Antonio Bianco, USA

Marina Nikolic Djurovic, Serbia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):16.

10.00–10.10 OP-07–46 SELENO-METHIONINE EXERTS PROTECTIVE EFFECTS AGAINST H2O2-INDUCED OXIDATIVE STRESS IN THYROCYTES AND FIBROBLASTS CELLS


Presenting Author: Rosaria Ruggeri, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):16.

10.15–10.25 OP-07–47 THE CHICKEN OPTIC TECTUM AS A CONVENIENT MODEL TO STUDY MCT8-DEFICIENT CORTICOGENESIS


Presenting Author: Pieter Vancamp, Belgium

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):16.

10.30–10.40 OP-07–48 ALTERED DEVELOPMENT OF THE CEREBRAL COMMISSURES IN TRANSIENT EARLY POSTNATAL HYPOTHYROID RATS: CORRELATION BETWEEN MRI AND EM


Presenting Author: Federico Salas, Spain

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):16.

10.45–10.55 OP-07–49 EFFECTS OF 3-IODOTHYRONAMINE (T1AM) ON SIGNALING PATHWAYS INVOLVED IN SYNAPTIC PLASTICITY AND NEUROPROTECTION


Presenting Author: Ginevra Sacripanti, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):16.

11.00–11.10 OP-07–50 LOCAL CONTROL OF THYROID HORMONE AVAILABILITY IN THE ADULT NEURAL STEM NICHE


Presenting Author: Cristina Luongo, France

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):16.

11.15–11.25 OP-07–51 POLYPHENOLS FROM CITRUS FRUITS INDUCE STRUCTURAL AND IMMUNOHISTOCHEMICAL CHANGES IN THYROIDS OF OLD-AGED MALE WISTAR RATS


Presenting Author: Marko Miler, Serbia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):16.

11.30–11.40 OP-07–52 A NEW SMALL MOLECULE TSH-RECEPTOR SELECTIVE ANTAGONIST TOWARDS GRAVES' ORBITOPATHY


Presenting Author: Patrick Marcinkowski, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):16.

11.45–11.55 OP-07–53 3-IODOTHYRONAMINE RESCUES BETA-AMYLOID-DEPENDENT INHIBITION OF LONG-TERM POTENTIATION IN VITRO AND RESTORES RECOGNITION MEMORY IN A MOUSE MODEL OF ALZHERIMER'S DISEASE


Presenting Author: Alice Accorroni, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):16.

12.00–13.00 Poster Session 3


P3-01-114 – P3-06-167 (for corresponding Abstracts, see pp. 96–113)

P3 – 01 Autoimmunity 3 (Room Adriatic)

Chair: Luigi Bartalena, Italy

P3 – 02 Cancer Case Reports (Room Tisa)

Chair: Slavica Ćirić, Serbia

P3 – 03 Cancer Treatment (Room Aegean)

Chair: Maria Alevizaki, Greece

P3 – 04 Case Reports, Goitre and Nodules 3 (Room Danube)

Chair: Andrzej Lewinski, Poland

P3 – 05 Clinical Thyroidology (Room Mediterranean)

Chair: Tim Korevaar, The Netherlands

P3 – 06 Iodine and Reproduction (Room Baltic)

Chair: John Lazarus, UK

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):16.

13.00–14.00 ETA Industry-Sponsored Satellite Symposium 5


(see p. 125 for details)

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):17.

Meet the Expert 5–8


Room Morava
14.00–14.45 MTE 5
Thyroid hormone and metabolism Eric Fliers, The Netherlands

Room Pacific
14.00–14.45 MTE 6
Natural history and prevention of thyroid eye disease Miloš; Žarković, Serbia
Room Atlantic 1
14.00–14.45 MTE 7
New model systems of thyroid organogenesis Robert Opitz, Germany
Room Atlantic 3
14.00–14.45 MTE 8
Circulating free nucleic acids in thyroid cancer Garcilaso Riesco-Eizaguirre, Spain
Eur Thyroid J. 2017 Aug 12;6(Suppl 1):17.

14.45–15.00 Coffee break


⁕

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):17.

15.00–17.00 Oral Session 8 (Clinical): Clinical Aspects of Pregnancy and Childhood


Chairs: Jasmina Ciric, Serbia

Kris Poppe, Belgium

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):17.

15.00–15.10 OP-08–54 MATERNAL AND PLACENTAL RESPONSES PRIOR TO PRETERM DELIVERY: COMPENSATORY ADAPTATIONS TO INCREASE THYROID HORMONE AVAILABILITY FOR THE PRETERM NEWBORN?


Presenting Author: An Eerdekens, Belgium

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):17.

15.15–15.25 OP-08–55 UNIVERSAL SALT IODINATION IN CROATIA MEETS IODINE REQUIREMENTS OF THE POPULATION – THE RESULT OF THE SIMPLIFY STUDY


Presenting Author: Tomislav Jukic, Croatia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):17.

15.30–15.40 OP-08–56 LIVE BIRTH RATE ACCORDING TO THYROXINE REPLACEMENT THERAPY IN THYROID PEROXIDASE ANTIBODY-POSITIVE WOMEN WITH RECURRENT PREGNANCY LOSS


Presenting Author: Sofie Bliddal, Denmark

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):17.

15.45–15.55 OP-08–57 SYSTEMATIC NGS ANALYSIS OF NEWBORNS WITH CONGENITAL HYPOTHYROIDISM RELATED TO DYSHORMONOGENESIS IN A FRENCH COHORT


Presenting Author: Frederique Savagner, France

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):17.

16.00–16.10 OP-08–58 IMPACT OF FIRST TRIMESTER OF PREGNANCY MATERNAL TSH IN OBSTETRICAL AND FETAL COMPLICATIONS: USEFULNESS OF 2.5 mUI/mL CUT-OFF VALUE


Presenting Author: Ines Velasco, Spain

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):17.

16.15–16.25 OP-08–59 THE ASSOCIATION OF THYROID FUNCTION WITH MATERNAL AND NEONATAL HOMOCYSTEINE CONCENTRATIONS


Presenting Author: Mirjana Barjaktarovic, The Netherlands

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):17.

16.30–16.40 OP-08–60 A DE NOVO DICER1 GERMLINE MUTATION IN A CHILD WITH MULTINODULAR GOITER


Presenting Author: Marek Niedziela, Poland

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):17.

16.45–16.55 OP-08–61 PREVIOUS CHILDBIRTH AND INDUCED ABORTIONS MAY PRECEDE LATER DEVELOPMENT OF HYPERTHYROIDISM, BUT ONLY IN GRAVES' DISEASE


Presenting Author: Allan Carle, Denmark

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):18.

15.00–17.00 Oral Session 9 (Basic): Cancer – Scientific Aspects 2


Chairs: Jelena Jankovic, Serbia

Garcilaso Riesco-Eizaguirre, Spain

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):18.

15.00–15.10 OP-09–62 COMBINED DETERMINATION OF CAVEOLIN-1, BRAF V600E AND EGFR IN FNAB SAMPLES DISCRIMINATES PATIENTS WITH HIGH AND LOW RISK OF AGGRESSIVE THYROID CANCER


Presenting Author: Jelena Jankovic, Serbia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):18.

15.15–15.25 OP-09–63 INHIBITION OF ERK DIMERIZATION AS A THERAPY FOR THYROID CANCER


Presenting Author: Miguel Zaballos, Spain

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):18.

15.30–15.40 OP-09–64 VANDETANIB IS ACTIVE AGAINST PRIMARY ANAPLASTIC THYROID CANCER IN VITRO AND IN VIVO


Presenting Author: Alessandro Antonelli, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):18.

15.45–15.55 OP-09–65 DISSECTING THE ROLE OF THYROTROPIN IN DNA DAMAGES RESPONSE OF HUMAN THYROCYTES IN PRIMARY CULTURES AFTER RADIOIODINE OR γ-RADIATION


Presenting Author: Aglaia Kyrilli, Belgium

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):18.

16.00–16.10 OP-09–66 IDENTIFICATION OF NOVEL SODIUM IODIDE SYMPORTER (NIS) INTERACTORS WHICH MODULATE IODIDE UPTAKE


Presenting Author: Alice Fletcher, UK

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):18.

16.15–16.25 OP-09–67 KIF5B/RET REARRANGEMENT IN DIFFUSE SCLEROSING VARIANT OF PAPILLARY THYROID CANCER (DSV-PTC)


Presenting Author: Carlotta Giani, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):18.

16.30–16.40 OP-09–68 COMPARISON OF GENE EXPRESSION PROFILE OF MEDULLARY THYROID TUMORS WITH RET AND RAS MUTATIONS


Presenting Author: Malgorzata Oczko-Wojciechowska, Poland

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):18.

16.45–16.55 OP-09–69 THE COMBINATION OF VEMURAFENIB AND TRAIL (TNF-RELATED APOPTOSIS INDUCING LIGAND) INDUCES EFFECTIVELY APOPTOSIS IN THE ANAPLASTIC THYROID CANCER CELLS


Presenting Author: Tania Pilli, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):18.

17.10–17.50 ETA Pinchera Prize Lecture


Chairs: Pilar Santisteban, Spain

Colin Dayan, UK

Tumor Suppressor Actions of the Thyroid Hormone Receptor

Ana Aranda, Spain

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):18.

18.00–19.15 General Assembly


⁕

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):18.

20.00–23.00 ETA – Network Dinner


(see p. 134 for details)

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):19.

Tuesday, 12th September 2017


⁕

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):19.

07.00–08.00 Short-Call Abstracts


Chair: Colin Dayan, UK

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):19.

08.00–08.30: Research Grant 2015 – Winner Presentations


Chairs: Furio Pacini, Italy

Theo Visser, The Netherlands

08.00–08.10 The nuclear corepressor 1 and the thyroid hormone receptor β suppress breast tumor lymphangiogenesis Elvira Alonso Merino, Spain
08.10–08.20 Anemia in patients with resistance to thyroid hormone alpha (RTHα): a role for TRα in human erythropoiesis Robin Peeters, The Netherlands
08.20–08.30 Mortality in Graves' orbitopathy is increased and influenced by gender, age and pre-existing morbidity Frans Brandt Kristensen, Denmark
Eur Thyroid J. 2017 Aug 12;6(Suppl 1):19.

08.30–10.30 Oral Session 10: Young Investigators/Clinical + Translational


Chairs: Eric Fliers, The Netherlands

George Kahaly, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):19.

08.30–08.45 OP-10–70 MATERNAL THYROID FUNCTION IN EARLY PREGNANCY AND CHILD NEURODEVELOPMENTAL DISORDERS: A DANISH NATIONWIDE CASE-COHORT STUDY OF 9,650 CHILDREN


Presenting Author: Stine Linding Andersen, Denmark

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):19.

08.50–09.05 OP-10–71 LENVATINIB FOR THE TREATMENT OF RADIO-IODINE REFRACTORY THYROID CANCER IN REAL-LIFE


Presenting Author: Amandine Berdelou, France

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):19.

09.10–09.25 OP-10–72 CHANGES IN PRESCRIPTION PRACTICES WHEN TREATING HYPOTHYROIDISM BETWEEN 2000 AND 2015 – A REGISTER-BASED STUDY FROM THE COPENHAGEN PRIMARY CARE LABORATORY (COPLAB) DATABASE


Presenting Author: Bjarke Borregaard Medici, Denmark

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):19.

09.30–09.45 OP-10–73 ASSOCIATION BETWEEN MATERNAL THYROID FUNCTION IN EARLY PREGNANCY AND OFFSPRING AUTISTIC TRAITS: AN INDIVIDUAL LEVEL META-ANALYSIS OF THREE PROSPECTIVE BIRTH COHORTS


Presenting Author: Deborah Levie, Spain

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):19.

09.50–10.05 OP-10–74 EXCESS MORTALITY IN HYPOTHYROID INDIVIDUALS IS AGGRAVATED BY OVERTREATMENT: DATA FROM A LONG-TERM POPULATION-BASED COHORT STUDY


Presenting Author: Mads Lillevang-Johansen, Denmark

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):19.

10.10–10.25 OP-10–75 INCREASED SERUM microRNAs ARE CLOSELY ASSOCIATED WITH THE PRESENCE OF RECURRENT/PERSISTENT DISEASE IN THYROID CANCER


Presenting Author: María Augusta Guillén, Spain

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):19.

08.30–10.30 Oral Session 11: Young Investigators/Basic


Chairs: Domenico Salvatore, Italy

Graham Richard Williams, UK

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):19.

08.30–08.45 OP-11–76 DICER1 DOWNREGULATION INDUCES CELL TRANSFORMATION IN THYROID CANCER


Presenting Author: Julia A. Ramirez-Moya, Spain

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

08.50–09.05 OP-11–77 REGULATION OF INTRACELLULAR T3 AVAILABILITY AND ACTION IS ESSENTIAL FOR OPTIMAL MACROPHAGE FUNCTION


Presenting Author: Anne van der Spek, The Netherlands

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

09.10–09.25 OP-11–78 ANTI-hTERT siRNA NANOPARTICLES BLOCK THE GROWTH OF ANAPLASTIC THYROID CANCER CELLS IN VITRO AND IN VIVO


Presenting Author: Giovanni Enrico Lombardo, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

09.30–09.45 OP-11–79 THE LONG NON-CODING RNA SPTYD1-AS1 IMPAIRS THYROID TUMORIGENESIS BY REPRESSING oncomiR ACTIVITY


Presenting Author: León Wert-Lamas, Spain

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

09.50–10.05 OP-11–80 THYROID HORMONE TRANSPORT BY OATP1A2 – CHARACTERISTICS AND GENETIC VARIATION


Presenting Author: Stefania Farina, The Netherlands

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

10.10–10.25 OP-11–81 KNOCKDOWN OF THE SELENOCYSTEINE INSERTION SEQUENCE-BINDING PROTEIN 2 (Secisbp2) GENE LEADS TO A MULTISYSTEM DISORDER IN ZEBRAFISH


Presenting Author: Federica Marelli, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

10.30–11.00 Coffee break


⁕

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

11.00–13.00 Oral Session 12 (Clinical): Clinical Thyroidology


Chairs: Biljana Beleslin, Serbia

Ulla Feldt-Rasmussen, Denmark

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

11.00–11.10 OP-12–82 ASSOCIATION BETWEEN SERUM 3-IODOTHYRONAMINE (T1AM) LEVELS AND LEFT VENTRICULAR PERFORMANCE IN CHRONIC HEART FAILURE (CHF)


Presenting Author: Jeppe Lerche la Cour, Denmark

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

11.15–11.25 OP-12–83 ORAL THYROXINE AND THE SPECTRUM OF GASTRIC pH: THE IN VIVO STUDY


Presenting Author: Camilla Virili, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

11.30–11.40 OP-12–84 TRENDS IN COSTS OF THYROID DISEASE TREATMENT IN DENMARK DURING 1995–2015: THE EFFECT OF IODINE FORTIFICATION


Presenting Author: Line Tang Moellehave, Denmark

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

11.45–11.55 OP-12–85 FIVE- AND TEN-YEAR FOLLOW-UP OF PATIENTS WITH THYROID NODULES IN AN IODINE-SUFFICIENT AREA – A PILOT STUDY


Presenting Author: Katica Bajuk Studen, Slovenia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

12.00–12.10 OP-12–86 IODINE FORTIFICATION ONLY INCREASED THE INCIDENCE OF OVERT HYPOTHYROIDISM MODESTLY – A 16-YEAR DANISH PROSPECTIVE POPULATION STUDY


Presenting Author: Mads Petersen, Denmark

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

12.15–12.25 OP-12–87 RELATIONSHIP BETWEEN AUTONOMIC NERVOUS FUNCTION AND CIRCADIAN BLOOD PRESSURE RHYTHM IN PATIENTS WITH HYPOTHYROIDISM


Presenting Author: Gen Yasuda, Japan

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

12.30–12.40 OP-12–88 THE HYPOTHYROID STATE IS ASSOCIATED WITH A REDUCED BRAIN VOLUME


Presenting Author: Till Ittermann, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

12.45–12.55 OP-12–89 EXCESS MORTALITY IN TREATED AND UNTREATED HYPERTHYROIDISM IS RELATED TO CUMULATIVE PERIODS OF LOW TSH


Presenting Author: Mads Lillevang-Johansen, Denmark

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

11.00–13.00 Oral Session 13 (Basic): Actions of Thyroid Hormone and Its Metabolites


Chairs: John Howard Duncan Bassett, UK

Jasmina Ciric, Serbia

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):20.

11.00–11.10 OP-13–90 EFFECTS OF 3,5-DIIODO-L-THYRONINE ON THE CARDIAC TISSUE


Presenting Author: Minh Nguyen, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):21.

11.15–11.25 OP-13–91 INDUCTION OF HYPOTHYROIDISM AND INFLAMMATION IN A NEW ANIMAL MODEL OVEREXPRESSING INTERLEUKIN-4 IN THE THYROID


Presenting Author: Xavier De Deken, Belgium

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):21.

11.30–11.40 OP-13–92 ASSAY OF ENDOGENOUS 3,5-DIIODO-L-THYRONINE (3,5-T2) AND 3,3′-DIIODO-L-THYRONINE (3,3′-T2) IN HUMAN SERUM


Presenting Author: Leonardo Lorenzini, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):21.

11.45–11.55 OP-13–93 A NOVEL ROLE FOR THE HIPPO PATHWAY IN THYROID DIFFERENTIATION


Presenting Author: Celia Fernández Méndez, Spain

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):21.

12.00–12.10 OP-13–94 3,5 DIIODO-L-THYRONINE (T2) TARGETS DIFFERENT PATHWAYS TO INDUCE WHITE ADIPOSE TISSUE BROWNING


Presenting Author: Rosalba Senese, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):21.

12.15–12.25 OP-13–95 THE OBESITY-RESISTANT WSB/EiJ MOUSE MAINTAINS METABOLIC HOMEOSTASIS DURING AGING DESPITE LOW CIRCULATING THYROID HORMONE LEVELS


Presenting Author: Marie-Stéphanie Clerget-Froidevaux, France

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):21.

12.30–12.40 OP-13–96 A SENSITIVE LC-MS/MS METHOD FOR THE DETERMINATION OF TRACE DI-IODOTHYRONINES IN HUMAN BLOOD SERUM


Presenting Author: Josef Köhrle, Germany

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):21.

12.45–12.55 OP-13–97 THE DEGREE OF FATTY ACID SATURATION INFLUENCES THE EFFECTS OF T3 AND 3,5-T2 ON INSULIN SENSITIVITY IN MUSCLE CELLS


Presenting Author: Pieter de Lange, Italy

Eur Thyroid J. 2017 Aug 12;6(Suppl 1):21.

13.10–14.40 Symposium 5 (Translational): Nonclassical Action of Thyroid Hormone


Chairs: Karine Gauthier-Vanacker, France

Sonja Selemetjev, Serbia

13.10–13.40 Nonclassical action of thyroid hormone receptors alpha and beta Lars Christian Möller, Germany
13.40–14.10 Nonclassical action of thyroid hormone receptors in fibrosis Ana Aranda, Spain
14.10–14.40 The role of thyroid hormone receptor sumoylation Gregory Brent, USA
Eur Thyroid J. 2017 Aug 12;6(Suppl 1):21.

13.10–14.40 Symposium 6 (Basic): Thyroid Cancer Treatment: Classic and Innovative Approaches


Chairs: Svetozar Damjanovic, Serbia

Thera Links, The Netherlands

13.10–13.40 Total thyroidectomy or lobectomy Dagmar Führer-Sakel, Germany
13.40–14.10 Novel surgical approaches Paolo Miccoli, Italy
14.10–14.40 Surveillance Robert Michael Tuttle, USA
Eur Thyroid J. 2017 Aug 12;6(Suppl 1):21.

14.40–15.00 Prize Ceremony and Closure


Chairs: Pilar Santisteban, Spain

Colin Dayan, UK

Visit the Karger booth at the ETA exhibition and profit from an introductory price

graphic file with name etj-0006-0001-gu05.jpg

Graves' Orbitopathy

A Multidisciplinary Approach – Questions and Answers 3rd, revised and expanded edition Editors: Wiersinga, W.M. (Amsterdam); Kahaly, G.J. (Mainz)

XVIII + 358 p., 116 fig., 69 in color, 52 tab., 2017 Introductory price: CHF 96.00 / EUR 90.00 / USD 113.00 (soft cover)

Soft cover or online prices for personal customers

Prices subject to change, VAT not included EUR price for eurozone countries,

USD price for USA and Latin America only

ISBN 978-3-318-06084-3

e-ISBN 978-3-318-06085-0

graphic file with name etj-0006-0001-gu06.jpg

Dear Librarian

I have reviewed this publication and would like to recommend it for our library.

Recommended by:

Department:

Date:

Signature:

Orders may be placed with any bookshop, subscription agency, directly with the publisher or through a Karger representative.

Ten years ago, the first edition of Graves' Orbitopathy: A Multidisciplinary Approach was published. Since then, the book has become very popular and much has happened in the field to warrant a third edition. What has not changed is the successful and attractive question-and-answer format of the book.

In the 3rd, revised and expanded edition, new chapters have been added on comorbidity, local treatment modalities, novel immunosuppressive therapy, detailed protocols, and questions frequently asked by patients. All chapters of the previous edition have been thoroughly updated. Subjects covered then include the pathology of Graves' orbitopathy (GO) and the controversial views on its pathogenesis; assessment of changes using reliable measuring techniques; medical management of GO including established and alternative treatment options; technical explanations and illustrations of various surgical procedures; and finally, the molecular, immunologic, and clinical aspects of this complex disorder. Additionally, ample consideration is given to the new 2016 ETA/EUGOGO guidelines on the management of GO.

Contents

Preface to the Third, Revised and Expanded Edition

Preface to the Second, Revised Edition:

Wiersinga, W.M.; Kahaly, G.J.

Preface to the First Edition: Wiersinga, W.M.;

Kahaly, G.J.

Diagnosis and Pathogenesis

  • Clinical Manifestations: Dickinson, A.J.; Hintschich, C.

  • Orbit-Thyroid Relationship: Marinò, M.

  • Epidemiology: Burlacu, M.-C.; Daumerie, C.

  • Pathogenesis: Salvi, M.; Berchner-Pfannschmidt, U.; Ludgate, M.

  • Orbital Imaging: Pitz, S.; Müller-Forell, W.

  • Diagnosis and Differential Diagnosis of Graves' Orbitopathy: Konuk, O.; Anagnostis, P.

  • Natural History: Mamoojee, Y.; Pearce, S.H.S.

    Management

  • General Management Plan for Graves' Orbitopathy: Bartalena, L.

  • Combined Thyroid-Eye Clinics: Törüner, F.B.; Konuk, O.; Ayvaz, G.

  • Thyroid Treatment: Hegedüs, L.; Brix, T.H.

  • Management of Mild Graves' Orbitopathy: Marcocci, C.; Rocchi, R.

  • Management of Moderately Severe Graves' Orbitopathy: Kahaly, G.J.

  • Novel Immunomodulatory Treatment Modalities: Lane, L.C.; Perros, P.; Pearce, S.H.S.

  • Management of Very Severe Graves' Orbitopathy: Dysthyroid Optic Neuropathy and Corneal Breakdown: Boschi, A.; Currò, N.

  • Local Treatment Modalities: Boboridis, K.; Anagnostis, P.

  • Rehabilitative Surgery: Baldeschi, L.

  • Orbital Decompression: Baldeschi, L.; Morris, D.S.

  • Eye Muscle Surgery: Nardi, M.; Eckstein, A.

  • Eyelid Surgery: Clarke, L.; Eckstein, A.

    Miscellaneous Issues

  • Quality of Life: Wiersinga, W.M.

  • Socioeconomic Impact: Kahaly, G.J.

  • The Patient's View: von Arx, G.; Ayvaz, G.

  • Atypical Manifestations: Daumerie, C.; Fichter, N.

  • Childhood Graves' Orbitopathy: Bartalena, L.

  • Comorbidity in Graves' Orbitopathy: Žarković, M., KneŽević, M.

  • Prevention: Marcocci, C.; Marinò, M.

  • Protocols of Non-Surgical Therapies: Bartalena, L.

  • The Amsterdam Declaration on Graves' Orbitopathy: Perros, P.

  • Historical Notes on Graves' Disease: Perros, P.

Author Index/Subject Index

For easy pre-ordering, please go to: www.karger.com/graves

Karger – Medical and Scientific Publishers

CH–4009 Basel, Switzerland

orders@karger.com, f: +41 61 306 12 34

www.karger.com


Articles from European Thyroid Journal are provided here courtesy of Bioscientifica Ltd.

RESOURCES